OncLive - Clinical Oncology News, Cancer Expert Insights
OncLive - Clinical Oncology News, Cancer Expert Insights
Spotlight
OncClub: Join the Chat on Trending Trials in CancerComplimentary print subscription for home or office deliveryIn-person and virtual events just for HCPsLively expert panel discussions featuring peer-to-peer exchangesSubscribe to our eNewsletter for breaking news and curated content
Specialty
View MoreBreast CancerCAR T-cell TherapyChronic Lymphocytic LeukemiaGastrointestinal CancerGenitourinary CancersGynecologic OncologyImmuno-OncologyLung CancerMelanoma & Skin CancerMultiple MyelomaUrothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
Rare Cancer Series
Media
Insights
Medical World News
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Thoracic Night Live
Conferences
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live
Oncology Fellows
Supplements And Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Spotlight
  • OncClub: Join the Chat on Trending Trials in Cancer
  • Complimentary print subscription for home or office delivery
  • In-person and virtual events just for HCPs
  • Lively expert panel discussions featuring peer-to-peer exchanges
  • Subscribe to our eNewsletter for breaking news and curated content
SpecialtySee All >
  • Breast Cancer
  • CAR T-cell Therapy
  • Chronic Lymphocytic Leukemia
  • Gastrointestinal Cancer
  • Genitourinary Cancers
  • Gynecologic Oncology
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Multiple Myeloma
  • Urothelial Cancer
OncLive SOSS
  • Advertise
  • About OncLive
  • Editorial Board
  • CancerNetwork.com
  • CGTlive.com
  • CureToday.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Refining Treatment Approaches for HER2+ Breast Cancer

EP. 1: HR-/HER2+ Early Stage Breast Cancer: Standards of Care

January 20th 2021

EP. 2: Adjuvant Systemic Therapy Decision Factors

January 20th 2021

EP. 3: Adjuvant Systemic Therapy Data Updates

January 29th 2021

EP. 4: De-Escalation of Adjuvant Anti-HER2 Therapy and Chemo

January 29th 2021

EP. 5: Hormone Therapy in HER2+ Breast Cancer

February 5th 2021

EP. 6: Moving Metastatic Therapy to Early Stage Setting

February 5th 2021

EP. 7: Newly FDA Approved Therapies: R/R HER2+ MBC

February 12th 2021

EP. 8: Sequencing Therapy in R/R HER2+ MBC

February 12th 2021

EP. 9: Brain Metastases Therapy in Second-Line HER2+ MBC

February 19th 2021

EP. 10: Practical Advice for Toxicity Management in HER2+ MBC

February 19th 2021

EP. 11: Novel Agents for Late-Stage HER2+ MBC

February 26th 2021

EP. 12: Phase 3 FeDeriCa and PHranceSCa Trial Overviews

February 26th 2021

EP. 13: Decision Factors for SubQ Therapy and Unmet Needs

March 5th 2021